Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Moxidectin PK and Safety in Children With or Without Onchocerciasis
NCT01035619Phase 2Withdrawn
- Sponsor
- Pfizer
- Start
- Apr 2011
- Primary completion
- Apr 2011
- Modality
- Allosteric Modulators
01
Overview
A Phase 2 trial of moxidectin in onchocerciasis, sponsored by Pfizer. Planned start Apr 2011; status: withdrawn.
02
Drugs
moxidectin
03
Conditions
onchocerciasis
Beyond the preview
Go deeper on NCT01035619.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01035619.